These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16950579)

  • 21. An investigation into the characteristics and drug release properties of multiple W/O/W emulsion systems containing low concentration of lipophilic polymeric emulsifier.
    Vasiljevic D; Parojcic J; Primorac M; Vuleta G
    Int J Pharm; 2006 Feb; 309(1-2):171-7. PubMed ID: 16406403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and in vitro permeation study of microemulsions and liquid crystalline systems containing the anticholinesterase alkaloidal extract from Tabernaemontana divaricata.
    Chaiyana W; Rades T; Okonogi S
    Int J Pharm; 2013 Aug; 452(1-2):201-10. PubMed ID: 23680734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylcholine embedded micellar systems: enhanced permeability through rat skin.
    Spernath A; Aserin A; Sintov AC; Garti N
    J Colloid Interface Sci; 2008 Feb; 318(2):421-9. PubMed ID: 18005978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass transport properties of progesterone and estradiol in model microemulsion formulations.
    Land LM; Li P; Bummer PM
    Pharm Res; 2006 Oct; 23(10):2482-90. PubMed ID: 16927186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation design of microemulsion for dermal delivery of penciclovir.
    Zhu W; Yu A; Wang W; Dong R; Wu J; Zhai G
    Int J Pharm; 2008 Aug; 360(1-2):184-90. PubMed ID: 18541394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation of a cosurfactant-free O/W microemulsion using nonionic surfactant mixtures.
    Cho YH; Kim S; Bae EK; Mok CK; Park J
    J Food Sci; 2008 Apr; 73(3):E115-21. PubMed ID: 18387105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies.
    Raza K; Negi P; Takyar S; Shukla A; Amarji B; Katare OP
    J Microencapsul; 2011; 28(3):190-9. PubMed ID: 21395406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pickering w/o emulsions: drug release and topical delivery.
    Frelichowska J; Bolzinger MA; Valour JP; Mouaziz H; Pelletier J; Chevalier Y
    Int J Pharm; 2009 Feb; 368(1-2):7-15. PubMed ID: 18992799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and characterization of self-microemulsifying drug delivery system of tacrolimus for intravenous administration.
    Borhade VB; Nair HA; Hegde DD
    Drug Dev Ind Pharm; 2009 May; 35(5):619-30. PubMed ID: 18979309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of novel formulations to enhance in vivo transdermal permeation of tocopherol.
    Nada AH; Zaghloul AA; Hedaya MM; Khattab IS
    Acta Pharm; 2014 Sep; 64(3):299-309. PubMed ID: 25296676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system.
    Lv FF; Zheng LQ; Tung CH
    Int J Pharm; 2005 Sep; 301(1-2):237-46. PubMed ID: 16039810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration.
    Chen H; Mou D; Du D; Chang X; Zhu D; Liu J; Xu H; Yang X
    Int J Pharm; 2007 Aug; 341(1-2):78-84. PubMed ID: 17570625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation optimization of estradiol microemulsion using response surface methodology.
    Tsai YH; Fu LT; Huang CT; Chang JS; Huang YB; Wu PC
    J Pharm Sci; 2011 Oct; 100(10):4383-9. PubMed ID: 21544822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation.
    Savić S; Savić M; Tamburić S; Vuleta G; Vesić S; Müller-Goymann CC
    Eur J Pharm Sci; 2007 Apr; 30(5):441-50. PubMed ID: 17331708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The advantage of polymer addition to a non-ionic oil in water microemulsion for the dermal delivery of progesterone.
    Biruss B; Valenta C
    Int J Pharm; 2008 Feb; 349(1-2):269-73. PubMed ID: 17869457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an oral microemulsion formulation of alendronate: effects of oil and co-surfactant type on phase behaviour.
    Karamustafa F; Celebi N
    J Microencapsul; 2008 Aug; 25(5):315-23. PubMed ID: 18465302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quercetin in w/o microemulsion: in vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo.
    Vicentini FT; Simi TR; Del Ciampo JO; Wolga NO; Pitol DL; Iyomasa MM; Bentley MV; Fonseca MJ
    Eur J Pharm Biopharm; 2008 Aug; 69(3):948-57. PubMed ID: 18304790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyoxyethylene fatty acid esters as potential promotors of transdermal absorption for morphine hydrochloride and sulphate.
    Samczewska G; Piechota-Urbańska M; Kołodziejska J
    Polim Med; 2006; 36(2):17-32. PubMed ID: 17022153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innovative formulations for the delivery of levothyroxine to the skin.
    Padula C; Nicoli S; Santi P
    Int J Pharm; 2009 May; 372(1-2):12-6. PubMed ID: 19162148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical drug delivery by Sepineo P600 emulgel: Relationship between rheology, physical stability, and formulation performance.
    Badruddoza AZM; Zahid MI; Walsh T; Shah J; Gates D; Yeoh T; Nurunnabi M
    Int J Pharm; 2024 Jun; 658():124210. PubMed ID: 38718972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.